In April 2015, USAID and Janssen Therapeutics officially launched the bedaquiline donation initiative, under which Janssen committed to providing free bedaquiline to 30,000 patients with multidrug-resistant tuberculosis (MDR-TB) over a four-year period. Bedaquiline is the first anti-TB medicine to be approved by the U.S. Food and Drug Administration in more than 40 years, and is … Read more
Archive USAID
Leveraging Local Resources for Sustainable Pharmaceutical Management Interventions in Dominican Republic
![](https://siapsprogram.org/wp-content/uploads/2015/03/Leverage-of-resourses-in-DR-final-ap_Page_1.jpg)
This brief demonstrates how more than USD 102 million has been saved or mobilized as a result of SIAPS/USAID assistance in supporting the implementation of the National Pharmaceutical System in the Dominican Republic.
Beating Tuberculosis Requires More Than Medicine
![](https://siapsprogram.org/wp-content/uploads/2015/02/busisiwe.jpg)
By Emily Delmotte, SIAPS Technical Advisor This has been cross-posted with the permission of Science Speaks. The text has been changed slightly for clarity. Eight years ago Busisiwe Beko was undergoing treatment for multidrug-resistant tuberculosis (MDR-TB) when, after months of waiting to see a pediatric specialist, her daughter was diagnosed with the same illness. The … Read more